Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus

Brain

Volumn 125, Issue 11, 2002, Pages 2418-2430

  Nandi, Dipankar ^a   Aziz, Tipu Z ^a,b   Giladi, Nir ^c   Winter, Jonathan ^a   Stein, John F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Akinesia; Bicuculline; Gamma aminobutyric acid; Pedunculopontine nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BENSERAZIDE PLUS LEVODOPA; BICUCULLINE METHIODIDE; MUSCIMOL;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FEMALE; MALE; MICROINJECTION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSONISM; PONS; PRIORITY JOURNAL; RATING SCALE; RHESUS MONKEY; SYMPTOMATOLOGY; TREMOR;

EID: 0036846743     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf259     Document Type: Article

References (49)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. [Review]. Trends Neurosci 1989; 12: 366-75.
2. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991; 6: 288-92.
3. Aziz TZ, Davies L, Stein J, France S. The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia. Br J Neurosurg 1998; 12: 245-9.
4. Baron MS, Wichmann T, Ma D, DeLong MR. Effects of transient focal inactivation of the basal ganglia in parkinsonian primates. J Neurosci 2002; 22: 592-9.
5. Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P. Long-term electrical inhibition of deep brain targets in movement disorders. [Review]. Mov Disord 1998; 13 Suppl 3: 119-25.
6. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249: 1436-8.
7. Beurrier C, Bezard E, Bioulac B, Gross C. Subthalamic stimulation elicits hemiballismus in normal monkey. Neuroreport 1997; 8: 1625-9.
8. Clarke CE, Sambrook MA, Mitchell IJ, Crossman AR. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine (MPTP). J Neurol Sci 1987; 78: 273-80.
9. Crossman AR, Sambrook MA, Jackson A. Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain 1984; 107: 579-96.
10. DeLong M. Primate models of movement disorders of basal ganglia origin. [Review]. Trends Neurosci 1990; 13: 281-5.
11. Dubach MF, Tongen VC, Bowden DM. Techniques for improving stereotaxic accuracy in Macaca fascicularis. J Neurosci Methods 1985; 13: 163-9.
12. Edley SM, Graybiel AM. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J Comp Neurol 1983; 217: 187-215.
13. Eidelberg E, Walden JG, Nguyen LH. Locomotor control in macaque monkeys. Brain 1981; 104: 647-63.
14. Eidelberg E, Brooks BA, Morgan WW, Walden JG, Kokemoor RH. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys. Neuroscience 1986; 18: 817-22.
15. Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, et al. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 1998; 401: 253-65.
16. Garcia-Rill E, Houser CR, Skinner RD, Smith W, Woodward DJ. Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus. Brain Res Bull 1987; 18: 731-8.
17. Geula C, Schatz CR, Mesulam MM. Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 1993; 54: 461-76.
18. Granata AR, Kitai ST. Inhibitory substantia nigra inputs to the pedunculopontine neurons. Exp Brain Res 1991; 86: 459-66.
19. Iacono RP, Lonser RR, Mandybur G, Morenski JD, Yamada S, Shima F. Stereotactic pallidotomy results for Parkinson's exceed those of fetal graft. [Review]. Am Surg 1994; 60: 777-82.
20. Imai H. Clinicophysiological features of akinesia. [Review]. Eur Neurol 1996; 36 Suppl 1: 9-12.
21. Imbert C, Bezard E, Gross CE. A new rating scale for the assessment of MPTP-induced parkinsonism in monkeys. Fr Soc Neurosci Bordeaux 1997; 3: 212.
22. Jellinger KA. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988; 51: 540-3.
23. Keating GL, Rye DB. Functional organization of brainstem-basal ganglia interactions as viewed from the pedunculopontine region. In: Kultas-Ilinsky K, Ilinsky IA, editors. Basal Ganglia and Thalamus in Health and Movement Disorders. New York: Kluwer Academic/Plenum Publishers; 2001. p. 175-88.
24. Kojima J, Yamaji Y, Matsumura M, Nambu A, Inase M, Tokuno H, et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci Lett 1997; 226: 111-4.
25. Kurlan R, Kim MH, Gash DM. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism. Mov Disord 1991; 6: 111-8.
26. Laitinen L, Vikki J, editors. Measurement of Parkinsonian Hypokinesia with Purdue Pegboard and Motor Reaction Time Tests, Vol. 2. Berlin: Huber; 1973.
27. Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 1994a; 344: 190-209.
28. Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: Projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 1994b; 344: 210-31.
29. Lozano AM, Lang AE. Pallidotomy for Parkinson's disease. [Review]. Neurosurg Clin N Am 1998; 9: 325-36.
30. Martin JH. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci Lett 1991; 127: 160-4.
31. Martin RF, Bowden DM. A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy. Neuroimage 1996; 4: 119-50.
32. Martin JH, Ghez C. Pharmacological inactivation in the analysis of the central control of movement. [Review]. J Neurosci Methods 1999; 86: 145-59.
33. Mesulam MM, Geula C, Bothwell MA, Hersh LB. Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 1989; 283: 611-33.
34. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989; 32: 213-26.
35. Munro-Davies LE, Winter J, Aziz TZ, Stein JF. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia. Exp Brain Res 1999; 129: 511-7.
36. Nandi D, Liu X, Winter JL, Miall RC, Aziz TZ, Stein JF. Frequency-dependent effects of chronic deep brain stimulation of the pedunculopontine region in a normal non-human primate. J Physiol 2001; 533.P: 68P.
37. Nandi D, Liu X, Winter JL, Aziz TZ, Stein JF. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. J Clin Neurosci 2002; 9: 170-4.
38. Noda T, Oka H. Distribution and morphology of tegmental neurons receiving nigral inhibitory inputs in the cat: an intracellular HRP study. J Comp Neurol 1986; 244: 254-66.
39. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. [Review]. Brain 2000; 123: 1767-83.
40. Rye DB, Lee HJ, Saper CB, Wainer BH. Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat. J Comp Neurol 1988; 269: 315-41.
41. Schneider JS, Lidsky TI, Hawks T, Mazziotta JC, Hoffman JM. Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Brain Res 1995; 672: 112-7.
42. Scott R, Gregory R, Hines N, Carroll C, Hyman N, Papanasstasiou V, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain 1998; 121: 659-75.
43. Shink E, Sidibe M, Smith Y. Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus. J Comp Neurol 1997; 382: 348-63.
44. Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 1993; 52: 7-16.
45. Spann BM, Grofova I. Origin of ascending and spinal pathways from the nucleus tegmenti pedunculopontinus in the rat. J Comp Neurol 1989; 283: 13-27.
46. Spann BM, Grofova I. Nigropedunculopontine projection in the rat: an anterograde tracing study with phaseolus vulgaris-leucoagglutinin (PHA-L). J Comp Neurol 1991; 311: 375-88.
47. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. [Review]. Curr Opin Neurobiol 1996; 6: 751-8.
48. Woolf NJ, Butcher LL. Cholinergic systems in the rat brain. III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia and basal forebrain. Brain Res Bull 1986; 16: 603-37.
49. Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989; 26: 41-6.